Publication date: Jul 04, 2025
The US Food and Drug Administration (FDA) has provided an update on the risk of myocarditis after receiving an mRNA COVID-19 vaccine, noting the risk is higher in young men. Indeed, the agency is to carry out a benefit-risk assessment on these jabs based on the latest reported rates of myocarditis and pericarditis from the 2023-2024 season, which number around 8. 4 per million vaccine doses. Declin .. .
| Concepts | Keywords |
|---|---|
| Fda | Administration |
| Food | Assessment |
| Myocarditis | Covid |
| Vaccination | Drug |
| Fda | |
| Food | |
| Jabs | |
| Mrna | |
| Myocarditis | |
| Provided | |
| Rates | |
| Receiving | |
| Risk | |
| Update | |
| Vaccine |
Semantics
| Type | Source | Name |
|---|---|---|
| drug | DRUGBANK | Pirenzepine |
| disease | MESH | PANIC |
| disease | IDO | object |
| disease | IDO | site |
| disease | MESH | COVID-19 |
| disease | MESH | myocarditis |
(Visited 3 times, 1 visits today)